These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 20649603

  • 1. Darbepoetin-mediated cardioprotection after myocardial infarction involves multiple mechanisms independent of erythropoietin receptor-common beta-chain heteroreceptor.
    Kanellakis P, Pomilio G, Agrotis A, Gao X, Du XJ, Curtis D, Bobik A.
    Br J Pharmacol; 2010 Aug; 160(8):2085-96. PubMed ID: 20649603
    [Abstract] [Full Text] [Related]

  • 2. Activator protein-2α mediates carbon monoxide-induced stromal cell-derived factor-1α expression and vascularization in ischemic heart.
    Lin HH, Chen YH, Chiang MT, Huang PL, Chau LY.
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):785-94. PubMed ID: 23393395
    [Abstract] [Full Text] [Related]

  • 3. Post-infarct treatment with [Pyr(1)]apelin-13 improves myocardial function by increasing neovascularization and overexpression of angiogenic growth factors in rats.
    Azizi Y, Faghihi M, Imani A, Roghani M, Zekri A, Mobasheri MB, Rastgar T, Moghimian M.
    Eur J Pharmacol; 2015 Aug 15; 761():101-8. PubMed ID: 25936512
    [Abstract] [Full Text] [Related]

  • 4. Erythropoietin attenuates cardiac dysfunction by increasing myocardial angiogenesis and inhibiting interstitial fibrosis in diabetic rats.
    Lu J, Yao YY, Dai QM, Ma GS, Zhang SF, Cao L, Ren LQ, Liu NF.
    Cardiovasc Diabetol; 2012 Sep 07; 11():105. PubMed ID: 22954171
    [Abstract] [Full Text] [Related]

  • 5. Exendin-4 induces myocardial protection through MKK3 and Akt-1 in infarcted hearts.
    Du J, Zhang L, Wang Z, Yano N, Zhao YT, Wei L, Dubielecka-Szczerba P, Liu PY, Zhuang S, Qin G, Zhao TC.
    Am J Physiol Cell Physiol; 2016 Feb 15; 310(4):C270-83. PubMed ID: 26739490
    [Abstract] [Full Text] [Related]

  • 6. Qiliqiangxin improves cardiac function and attenuates cardiac remodeling in rats with experimental myocardial infarction.
    Wang J, Zhou J, Ding X, Zhu L, Jiang K, Fu M, Wang S, Hu K, Ge J.
    Int J Clin Exp Pathol; 2015 Feb 15; 8(6):6596-606. PubMed ID: 26261541
    [Abstract] [Full Text] [Related]

  • 7. Sepiapterin enhances angiogenesis and functional recovery in mice after myocardial infarction.
    Shimazu T, Otani H, Yoshioka K, Fujita M, Okazaki T, Iwasaka T.
    Am J Physiol Heart Circ Physiol; 2011 Nov 15; 301(5):H2061-72. PubMed ID: 21890687
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Erythropoietin stimulates normal endothelial progenitor cell-mediated endothelial turnover, but attributes to neovascularization only in the presence of local ischemia.
    Westenbrink BD, Oeseburg H, Kleijn L, van der Harst P, Belonje AM, Voors AA, Schoemaker RG, de Boer RA, van Veldhuisen DJ, van Gilst WH.
    Cardiovasc Drugs Ther; 2008 Aug 15; 22(4):265-74. PubMed ID: 18327705
    [Abstract] [Full Text] [Related]

  • 10. Experimental acute myocardial infarction in rats: HIF-1α, caspase-3, erythropoietin and erythropoietin receptor expression and the cardioprotective effects of two different erythropoietin doses.
    Guven Bagla A, Ercan E, Asgun HF, Ickin M, Ercan F, Yavuz O, Bagla S, Kaplan A.
    Acta Histochem; 2013 Sep 15; 115(7):658-68. PubMed ID: 23453036
    [Abstract] [Full Text] [Related]

  • 11. Novel, selective EPO receptor ligands lacking erythropoietic activity reduce infarct size in acute myocardial infarction in rats.
    Kiss K, Csonka C, Pálóczi J, Pipis J, Görbe A, Kocsis GF, Murlasits Z, Sárközy M, Szűcs G, Holmes CP, Pan Y, Bhandari A, Csont T, Shamloo M, Woodburn KW, Ferdinandy P, Bencsik P.
    Pharmacol Res; 2016 Nov 15; 113(Pt A):62-70. PubMed ID: 27521836
    [Abstract] [Full Text] [Related]

  • 12. 2-methoxycinnamaldehyde from Cinnamomum cassia reduces rat myocardial ischemia and reperfusion injury in vivo due to HO-1 induction.
    Hwa JS, Jin YC, Lee YS, Ko YS, Kim YM, Shi LY, Kim HJ, Lee JH, Ngoc TM, Bae KH, Kim YS, Chang KC.
    J Ethnopharmacol; 2012 Jan 31; 139(2):605-15. PubMed ID: 22179023
    [Abstract] [Full Text] [Related]

  • 13. Chronic urocortin 2 administration improves cardiac function and ameliorates cardiac remodeling after experimental myocardial infarction.
    Ellmers LJ, Scott NJ, Cameron VA, Richards AM, Rademaker MT.
    J Cardiovasc Pharmacol; 2015 Mar 31; 65(3):269-75. PubMed ID: 25658462
    [Abstract] [Full Text] [Related]

  • 14. Positive effect of darbepoetin on peri-infarction remodeling in a porcine model of myocardial ischemia-reperfusion.
    Toma C, Letts DP, Tanabe M, Gorcsan J, Counihan PJ.
    J Mol Cell Cardiol; 2007 Aug 31; 43(2):130-6. PubMed ID: 17597149
    [Abstract] [Full Text] [Related]

  • 15. Short- and long-term cardioprotective effect of darbepoetin-alpha: role of Bcl-2 family proteins.
    Schlecht-Bauer D, Antier D, Machet MC, Hyvelin JM.
    J Cardiovasc Pharmacol; 2009 Sep 31; 54(3):223-31. PubMed ID: 19597369
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of Mas G-protein signaling improves coronary blood flow, reduces myocardial infarct size, and provides long-term cardioprotection.
    Zhang T, Li Z, Dang H, Chen R, Liaw C, Tran TA, Boatman PD, Connolly DT, Adams JW.
    Am J Physiol Heart Circ Physiol; 2012 Jan 01; 302(1):H299-311. PubMed ID: 22003054
    [Abstract] [Full Text] [Related]

  • 17. Therapeutic administration of IL-11 exhibits the postconditioning effects against ischemia-reperfusion injury via STAT3 in the heart.
    Obana M, Miyamoto K, Murasawa S, Iwakura T, Hayama A, Yamashita T, Shiragaki M, Kumagai S, Miyawaki A, Takewaki K, Matsumiya G, Maeda M, Yoshiyama M, Nakayama H, Fujio Y.
    Am J Physiol Heart Circ Physiol; 2012 Sep 01; 303(5):H569-77. PubMed ID: 22707562
    [Abstract] [Full Text] [Related]

  • 18. Darbepoetin alfa, a long-acting erythropoietin analog, offers novel and delayed cardioprotection for the ischemic heart.
    Gao E, Boucher M, Chuprun JK, Zhou RH, Eckhart AD, Koch WJ.
    Am J Physiol Heart Circ Physiol; 2007 Jul 01; 293(1):H60-8. PubMed ID: 17384131
    [Abstract] [Full Text] [Related]

  • 19. IL-10 inhibits inflammation and attenuates left ventricular remodeling after myocardial infarction via activation of STAT3 and suppression of HuR.
    Krishnamurthy P, Rajasingh J, Lambers E, Qin G, Losordo DW, Kishore R.
    Circ Res; 2009 Jan 30; 104(2):e9-18. PubMed ID: 19096025
    [Abstract] [Full Text] [Related]

  • 20. Cardioprotective and antiapoptotic effects of heme oxygenase-1 in the failing heart.
    Wang G, Hamid T, Keith RJ, Zhou G, Partridge CR, Xiang X, Kingery JR, Lewis RK, Li Q, Rokosh DG, Ford R, Spinale FG, Riggs DW, Srivastava S, Bhatnagar A, Bolli R, Prabhu SD.
    Circulation; 2010 May 04; 121(17):1912-25. PubMed ID: 20404253
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.